KILITCH DRUGS (INDIA)
Back to Income Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹30 Cr | ₹27 Cr | ₹15 Cr | ₹10 Cr | ₹7.37 Cr |
What is the latest Consolidated Net Profit of KILITCH DRUGS (INDIA) ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹30 Cr |
| Mar2025 | ₹27 Cr |
| Mar2024 | ₹15 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹7.37 Cr |
How is Consolidated Net Profit of KILITCH DRUGS (INDIA) Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹30 Cr | 12.98 | |
| Mar2025 | ₹27 Cr | 82.87 | |
| Mar2024 | ₹15 Cr | 39.75 | |
| Mar2023 | ₹10 Cr | 41.82 | |
| Mar2022 | ₹7.37 Cr | - | |
Compare Consolidated Net Profit of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹654.2 Cr | 1.9% | -5.4% | 2.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 1.9% |
-5.4% |
2.6% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses